Skip to main content
SpringerLink
Log in

ASO Visual Abstract: A 3-Year Survival Update From a Phase II Study of Paclitaxel Plus Cisplatin and 5-Fluorouracil Induction Chemotherapy for Locally Advanced Borderline-Resectable Esophageal Squamous Cell Carcinoma: The NEOCRTEC-1601 Clinical Trial

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Author notes

  1. Jia-Di Wu, Zhi-Qiang Wang, Qiao-Qiao Li and Zhi-Chao Li contributed equally to this work.

Authors and Affiliations

  1. Department of Medical Oncology, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China

    Jia-Di Wu MD, Zhi-Qiang Wang MD, Qiao-Qiao Li MD, Zhi-Chao Li MD, Chao Ren MD, De-Shen Wang MD, Ji-Yang Chen MD, Qiong Tan MD, Yu-Hong Li MD & Hong Yang MD

Authors
  1. Jia-Di Wu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhi-Qiang Wang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qiao-Qiao Li MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhi-Chao Li MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chao Ren MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. De-Shen Wang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ji-Yang Chen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Qiong Tan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yu-Hong Li MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Hong Yang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yu-Hong Li MD.

Ethics declarations

DISCLOSURE

Jia-Di Wu, Zhi-Qiang Wang, Qiao-Qiao Li, Zhi-Chao Li, Chao Ren, De-Shen Wang, Ji-Yang Chen, Qiong Tan, Yu-Hong Li, and Hong Yang declare they have no conflicts of interest in relation to this work.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, JD., Wang, ZQ., Li, QQ. et al. ASO Visual Abstract: A 3-Year Survival Update From a Phase II Study of Paclitaxel Plus Cisplatin and 5-Fluorouracil Induction Chemotherapy for Locally Advanced Borderline-Resectable Esophageal Squamous Cell Carcinoma: The NEOCRTEC-1601 Clinical Trial. Ann Surg Oncol 31, 2527–2528 (2024). https://doi.org/10.1245/s10434-023-14801-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-14801-9

Search

Navigation